From the Journals

School-located influenza vaccination programs can be effective


 

FROM PEDIATRICS

School-located influenza vaccination (SLIV) increased seasonal influenza vaccination rates countywide and in both suburban and urban settings, a study found.

“Schools have a stake in influenza vaccination because immunization of schoolchildren can reduce absenteeism throughout the community. Nevertheless, only 6% of childhood influenza vaccinations occur at school. SLIV poses logistical challenges: obtaining parental consent, ordering and administering vaccine, and billing,” said Peter G. Szilagyi, MD, of Mattel Children’s Hospital, Los Angeles, and his associates.

Vaccine needle ©itsmejust/Thinkstock
By using both Web-based and paper consent for influenza vaccination among elementary school children, this SLIV program raised influenza vaccination rates countywide in suburban and urban school districts, with substantial use of Web-based consent for vaccination, the investigators said.

From 2014 to 2015, 44 elementary schools were randomized in upstate New York in an organized cluster-randomized trial in which 19,776 children were eligible candidates. Seven percent of SLIV school students, 5% of suburban SLIV school students, and 9% of urban SLIV students were vaccinated at SLIV clinics. Children in SLIV schools had higher flu vaccination rates than did children in control schools countywide (54% vs. 47%, P less than .001) and in suburban (62% vs. 54%, P less than .001) and urban schools (44% vs. 39%; P less than .001).

SLIV did substitute for vaccination for urban settings serving more Vaccines for Children–covered students, but did not substitute for practice-based vaccination in the suburbs, where pediatricians often preorder influenza vaccine.

“SLIV, using Web-based consent, is a potential strategy to improve influenza vaccination coverage among large populations of children,” the researchers concluded.

Read the full story here: Pediatrics. 2016. doi: 10.1542/peds.2016-1746.

Recommended Reading

Dengue vaccine beneficial only in moderate to high transmission settings
MDedge Infectious Disease
Unvaccinated patients rack up billions in preventable costs
MDedge Infectious Disease
ACIP approves change to hepatitis B vaccination guidelines
MDedge Infectious Disease
Use of 2D bar coding with vaccines may be the future in pediatric practice
MDedge Infectious Disease
ACIP approves changes to HPV, Tdap, DTaP, MenB vaccination guidance
MDedge Infectious Disease
2014-2015 influenza vaccine ineffective against predominant strain
MDedge Infectious Disease
Fatal measles complication occurs more often than realized
MDedge Infectious Disease
Study finds no increase in microcephaly with Tdap vaccine in pregnancy
MDedge Infectious Disease
Low parental confidence in HPV vaccine stymies adolescent vaccination rates
MDedge Infectious Disease
Another Zika vaccine heads to Phase I trials
MDedge Infectious Disease